{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:06:01Z","timestamp":1795046761147,"version":"4.10.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a clinical syndrome with various causes. It is not uncommon that COPD patients presenting with dyspnea have multiple causes for their symptoms including AECOPD, pneumonia, or congestive heart failure occurring concurrently.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To identify clinical, radiographic, and laboratory characteristics that might help distinguish AECOPD from another dominant disease in patients with a history of COPD, we conducted a retrospective cohort study of hospitalized patients with admitting diagnosis of AECOPD who were screened for a prospective randomized controlled trial from Sep 2016 to Mar 2018. Clinical characteristics, course in hospital, and final diagnosis at discharge were reviewed and adjudicated by two authors. The final diagnosis of each patient was determined based on the synthesis of all presenting signs and symptoms, imaging, and laboratory results. We adhered to AECOPD diagnosis definitions based on the GOLD guidelines. Univariate and multivariate analyses were performed to identify any associated features of AECOPD with and without other acute processes contributing to dyspnea.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three hundred fifteen hospitalized patients with admitting diagnosis of AECOPD were included. Mean age was 72.5 (SD 10.6) years. Two thirds (65.4%) had spirometry defined COPD. The most common presenting symptom was dyspnea (96.5%), followed by cough (67.9%), and increased sputum (57.5%). One hundred and eighty (57.1%) had a final diagnosis of AECOPD alone whereas 87 (27.6%) had AECOPD with other conditions and 48 (15.2%) did not have AECOPD after adjudication. Increased sputum purulence (OR 3.35, 95%CI 1.68\u20136.69) and elevated venous pCO2 (OR 1.04, 95%CI 1.01 \u2013 1.07) were associated with a diagnosis of AECOPD but these were not associated with AECOPD alone without concomitant conditions. Radiographic evidence of pleural effusion (OR 0.26, 95%CI 0.12 \u2013 0.58) was negatively associated with AECOPD with or without other conditions while radiographic evidence of pulmonary edema (OR 0.31; 95%CI 0.11 \u2013 0.91) and lobar pneumonia (OR 0.13, 95%CI 0.07 \u2013 0.25) suggested against the diagnosis of AECOPD alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study highlighted the complexity and difficulty of AECOPD diagnosis. A more specific clinical tool to diagnose AECOPD is needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02587-1","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T12:02:17Z","timestamp":1692014537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Alexandre J.","family":"Pratt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Purssell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa P. J.","family":"Luks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bauza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Mulpuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn D.","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthaporn","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"issue":"6","key":"2587_CR1","first-page":"1","volume":"61","author":"DL Hoyert","year":"2012","unstructured":"Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61(6):1\u201351.","journal-title":"Natl Vital Stat Rep"},{"key":"2587_CR2","doi-asserted-by":"publisher","unstructured":"Mathioudakis AG, Sivapalan P, Papi A, Vestbo J. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): Rationale and vision. Vol. 56, European Respiratory Journal. European Respiratory Society; 2020. Available from: https:\/\/doi.org\/10.1183\/13993003.00627-2020. [Cited 2020 Dec 2].","DOI":"10.1183\/13993003.00627-2020"},{"key":"2587_CR3","doi-asserted-by":"crossref","unstructured":"Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16611654\/. [Cited 2023 Apr 10].","DOI":"10.1183\/09031936.06.00124605"},{"issue":"2","key":"2587_CR4","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2213-2600(21)00561-0","volume":"10","author":"P Venkatesan","year":"2022","unstructured":"Venkatesan P. GOLD report: 2022 update. Lancet Respir Med. 2022;10(2):e20.","journal-title":"Lancet Respir Med"},{"key":"2587_CR5","doi-asserted-by":"crossref","unstructured":"Zhou A, Zhou Z, Zhao Y, Chen P. The recent advances of phenotypes in acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1009\u201318. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28392685. [Cited 2017 Nov 13].","DOI":"10.2147\/COPD.S128604"},{"key":"2587_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1183\/09059180.00008612","volume":"22","author":"A Cavaill\u00e8s","year":"2013","unstructured":"Cavaill\u00e8s A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, et al. Comorbidities of COPD. European Resp Rev. 2013;22:454\u201375.","journal-title":"European Resp Rev"},{"key":"2587_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1183\/09031936.00180812","volume":"41","author":"B Begh\u00e9","year":"2013","unstructured":"Begh\u00e9 B, Verduri A, Roca M, Fabbri LM. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. European Resp J. 2013;41:993\u20135.","journal-title":"European Resp J"},{"key":"#cr-split#-2587_CR8.1","doi-asserted-by":"crossref","unstructured":"Celli BR, Fabbri LM, Aaron SD, Agust\u00ed A, Brook RD, Criner GJ, et al. Differential Diagnosis of Suspected COPD Exacerbations in the Acute Care Setting: Best Practice. Am J Respir Crit Care Med. 2023 Jan 26","DOI":"10.1164\/rccm.202209-1795CI"},{"key":"#cr-split#-2587_CR8.2","unstructured":"Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36701677\/. [Cited 2023 Apr 10]."},{"key":"2587_CR9","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.2147\/COPD.S338849","volume":"2021","author":"J Cowan","year":"2021","unstructured":"Cowan J, Mulpuru S, Abdallah SJ, Chopra A, Purssell A, Mcguinty M, et al. A randomized double-blind placebo-control feasibility trial of immunoglobulin treatment for prevention of recurrent acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2021;2021:3275\u201384. https:\/\/doi.org\/10.2147\/COPD.S338849.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"2587_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1164\/rccm.201006-0833OC","volume":"183","author":"P Mallia","year":"2011","unstructured":"Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med. 2011;183(6):734\u201342.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2587_CR11","first-page":"44","volume":"6","author":"JR Hurst","year":"2018","unstructured":"Hurst JR. Consolidation and Exacerbation of COPD. Med Sci. 2018;6(2):44.","journal-title":"Med Sci"},{"issue":"1","key":"2587_CR12","doi-asserted-by":"publisher","first-page":"00282","DOI":"10.1183\/23120541.00282-2019","volume":"6","author":"SP Trethewey","year":"2020","unstructured":"Trethewey SP, Hurst JR, Turner AM. Pneumonia in exacerbations of COPD: what is the clinical significance? ERJ Open Res. 2020;6(1):00282\u20132019.","journal-title":"ERJ Open Res."},{"issue":"2","key":"2587_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1378\/chest.13-0790","volume":"145","author":"AS Gershon","year":"2014","unstructured":"Gershon AS, Hwee J, Croxford R, Aaron SD, To T. Patient and physician factors associated with pulmonary function testing for COPD: a population study. Chest. 2014;145(2):272\u201381.","journal-title":"Chest"},{"key":"2587_CR14","doi-asserted-by":"crossref","unstructured":"Zwar NA, Marks GB, Hermiz O, Middleton S, Comino EJ, Hasan I, et al. Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust. 2011;195(4):168\u201371. Available from: https:\/\/onlinelibrary-wiley-com.proxy.bib.uottawa.ca\/doi\/full\/10.5694\/j.1326-5377.2011.tb03271.x.","DOI":"10.5694\/j.1326-5377.2011.tb03271.x"},{"key":"2587_CR15","doi-asserted-by":"crossref","unstructured":"Walters JA, Walters EH, Nelson M, Robinson A, Scott J, Turner P, et al. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J J Gen Pract Airways Gr. 2011;20(4):396.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/21687918\/.","DOI":"10.4104\/pcrj.2011.00039"},{"key":"2587_CR16","doi-asserted-by":"crossref","unstructured":"Spero K, Bayasi G, Beaudry L, Barber KR, Khorfan F. Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2417.\u00a0\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/28860736\/.","DOI":"10.2147\/COPD.S139919"},{"key":"2587_CR17","doi-asserted-by":"crossref","unstructured":"Jain VV, Allison DR, Andrews S, Mejia J, Mills PK, Peterson MW. Misdiagnosis among frequent exacerbators of clinically diagnosed asthma and COPD in absence of confirmation of airflow obstruction. Lung. 2015;193(4):505\u201313.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/25921015\/. Cited 2023 Apr 10.","DOI":"10.1007\/s00408-015-9734-6"},{"issue":"6","key":"2587_CR18","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1378\/chest.117.6.1638","volume":"117","author":"RA Stockley","year":"2000","unstructured":"Stockley RA, O\u2019Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest. 2000;117(6):1638\u201345.","journal-title":"Chest"},{"key":"2587_CR19","doi-asserted-by":"crossref","unstructured":"Chen K, Pleasants KA, Pleasants RA, Beiko T, Washburn RG, Yu Z, et al. A Systematic Review and Meta-Analysis of Sputum Purulence to Predict Bacterial Infection in COPD Exacerbations. Vol. 17, COPD: Journal of Chronic Obstructive Pulmonary Disease. 2020.","DOI":"10.1080\/15412555.2020.1766433"},{"issue":"6","key":"2587_CR20","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1183\/09031936.00150211","volume":"40","author":"N Soler","year":"2012","unstructured":"Soler N, Esperatti M, Ewig S, Huerta A, Agusti C, Torres A. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Eur Respir J. 2012;40(6):1344\u201353.","journal-title":"Eur Respir J"},{"key":"2587_CR21","doi-asserted-by":"crossref","unstructured":"Daniels JMA, de Graaff CS, Vlaspolder F, Snijders D, Jansen HM, Boersma WG. Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease. Clin Microbiol Infect. 2010;16(6):583\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19681947\/. [Cited 2020 Dec 2].","DOI":"10.1111\/j.1469-0691.2009.02892.x"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02587-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02587-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02587-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T12:02:57Z","timestamp":1700481777000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02587-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2587"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02587-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"14 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Included patients in this study were identified from a prospective pilot randomized controlled trial (IPRAC) that aimed to determine feasibility of monthly intravenous immunoglobulin infusions for one year to prevent recurrent AECOPD in hospitalized patients with AECOPD from Sep 2016 to Mar 2018 []. The IPRAC study received institutional approval from the Ottawa Health Science Network Research Ethics Board (Protocol 20150925-01H, 20160077-01H, and 2017005-01H), which allowed for retrospective analysis of collected data from patients screened for eligibility. Written informed consent was obtained from participants who were eligible to the prospective IPRAC trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JC received honoraria from GSK, Merck, Sanofi Genzyme, Takeda, CSL Behring, Biogen unrelated to this work. MK is a consultant for VIDA Diagnostics Inc. (Coralville, IA, USA). AJP, AP, TZ, VL, XB, SM, SDA do not have competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}